MYC
MYC, also known as c-Myc, bHLHe39 and MYCC, is a basic helix-loop-helix transcription factor encoded by a proto-oncogene. It activates growth-related genes and has roles in cell cycle progression, apoptosis and cellular transformation. Browse Assay Genie's current range of MYC research reagents below, or read on for the biology behind the target.
MYC is a transcription factor that binds DNA in a non-specific manner, yet also specifically recognises the core sequence 5'-CAC[GA]TG-3'. In cells it forms a heterodimer with the related transcription factor MAX, and this complex binds the E box DNA consensus sequence to regulate transcription of specific target genes. MYC activates the transcription of growth-related genes, and works with TAF6L to activate target gene expression through RNA polymerase II pause release.
The protein is a nuclear phosphoprotein, found in the nucleoplasm and nucleolus, and UniProt also records it in the cytoplasm and on chromosomes. MYC binds the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis. It is a regulator of somatic reprogramming and controls self-renewal of embryonic stem cells. It also positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1, which bind repressively around PKM exon 9. This inhibits exon 9 inclusion, favours exon 10 inclusion and produces the PKM M2 isoform.
The MYC gene was previously named v-myc avian myelocytomatosis viral oncogene homolog, and belongs to the basic helix-loop-helix protein group. Amplification of the gene is frequently observed in numerous human cancers, and translocations involving it are associated with Burkitt lymphoma and multiple myeloma. Translation can initiate from an upstream in-frame non-AUG (CUG) site and a downstream AUG site, giving two isoforms with distinct N-termini. Related family member MYCN is covered separately.
MYC gene amplification is frequent across human cancers, and translocations are linked to Burkitt lymphoma and multiple myeloma.
MYC-MAX heterodimers bind E box sequences and, with TAF6L, drive target gene expression through RNA polymerase II pause release.
MYC regulates somatic reprogramming and controls self-renewal of embryonic stem cells.
MYC promotes VEGFA production and sprouting angiogenesis, and steers PKM splicing towards the M2 isoform via HNRNPA1, HNRNPA2 and PTBP1.
MYC is a transcription factor that recognises the core sequence 5'-CAC[GA]TG-3' and activates growth-related genes. It partners with MAX at E box elements, and it influences cell cycle progression, apoptosis, cellular transformation, angiogenesis via VEGFA, and embryonic stem cell self-renewal.
MYC is also called c-Myc, bHLHe39 and MYCC, and was formerly named v-myc avian myelocytomatosis viral oncogene homolog. Translation can start at an upstream CUG codon or a downstream AUG codon, producing two isoforms with distinct N-termini.
Amplification of the MYC gene is frequently seen in human cancers, and translocations are associated with Burkitt lymphoma and multiple myeloma. Orthologues named Myc exist in mouse and rat; check the datasheet of any product for its validated reactivity.
A related MYC family transcription factor with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01106; product specifications from Assay Genie datasheets.